The U.S. is divided when it comes to state and federal marijuana policy, but recent political developments could move the country toward greater acceptance of cannabis. Both major presidential candidates have signaled support for a proposed federal policy change that would reclassify marijuana as a less dangerous drug. Public approval of marijuana has grown significantly, and so has the number of states where it’s legally sold in stores. Several additional states will decide this fall whether to join 24 states and Washington, D.C., in legalizing the drug for recreation. A total of 38 states allow medical use of marijuana.
New research has determined that classic psychedelics including psilocybin and LSD are well tolerated in research and clinical settings, with rare adverse events occurring. For their study, the researchers focused on evaluating the severity, frequency and nature of adverse events linked to psilocybin, LSD, 5-MeO-DMT and DMT.
The researchers carried out a meta-analysis and systematic review that studied data obtained from 114 studies that involved more than 3,500 participants. The studies included were drawn from different databases, including Web of Science, PsycINFO, MEDLINE, and Scopus. The research covered studies published up to Feb. 8, 2024. They also had two independent reviewers who screened and selected studies that centered on research or clinical settings where the psychedelics were administered.
Adverse events were classified by type of study population and timescale, with the investigators applying a hybrid approach to include all reported adverse events following the administration of classic psychedelics. In addition, the researchers confirmed the presence of adverse events of special interest such as manic symptoms, suicidality, hallucinogen persisting perception disorder, cardiovascular events and psychotic disorders.
The investigators discovered that nonserious adverse events and serious adverse events that needed psychiatric or medical attention were rare in studies that involved the administration of classic psychedelics in monitored research or clinical settings. They found that only about 4% of participants with pre-existing neuropsychiatric disorders experienced serious adverse events, which included convulsive episodes, suicidal behavior, worsening depression and psychosis.
However, no severe adverse events were reported among healthy participants. Nonserious adverse events such as headaches and paranoia weren’t common either.
In modern research settings, the investigators found no reported cases of persistent psychotic disorders, death by suicide or hallucinogen-persisting perception disorder following the administration of psychedelics.
These findings demonstrate the difference in safety profiles between recreational and clinical settings, with the researchers finding that most catastrophic events reported in recreational use such as suicides and persistent psychotic disorders weren’t observed in trial participants. In their report, the researchers highlighted the need for more thorough pharmacovigilance practices to quantify the benefits and risks of psychedelics accurately.
The researchers also noted that concerns over incomplete adverse events reporting called attention to the need for improved safety monitoring as psychedelics gain more popularity in therapeutic use. Of all the studies evaluated, only 20 studies reported all adverse events and only 16 studies chronicled systematic approaches to adverse-event evaluation.
Researchers involved in the study included Jared T. Hinkle, Marianna Graziosi, Sandeep M. Nayak and David B. Yaden.
Startups in the psychedelics space such as atai Life Sciences N.V. (NASDAQ: ATAI) are likely to analyze the recommendations made by this study in order to glean insights that can enrich their efforts to develop psychedelic drugs that pass the scrutiny of regulators.
About PsychedelicNewsWire
PsychedelicNewsWire (“PNW”) is a specialized communications platform with a focus on all aspects of psychedelics and the latest developments and advances in the psychedelics sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, PNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, PNW brings its clients unparalleled recognition and brand awareness. PNW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from PsychedelicNewsWire, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
The Alt Pro Expo, presented by Trinity Hemp, is coming to Atlanta on Oct. 10-12, 2024. Atlanta has a vibrant history with a legacy of smoke-shop culture. The southern city attracts retailers and buyers from neighboring cities, blending seamlessly into the new-age Alternative Products scene. Atlanta offers several recreational options to the attendees of the Expo.
The Alternative Products Expo presents a dynamic platform for learning, exhibitions and collaborations in the Alternative Products industry. It brings together manufacturers, retailers, professionals, consumers, and enthusiasts, showcasing the latest products and services in the counterculture industry.
The Alternative Products Expo in Atlanta will offer unique opportunities to the local community. Alternative product traders can showcase their exhibits to world leaders, distributors, investors, and consumers looking for innovative products. They can set up booths, pitch their business ideas and products, or hold one-on-one conversations with potential investors and buyers.
The alternative product category includes a broad spectrum of herbal products, CBD, derivatives, vape products, energy boosts, mood changes, mushrooms, functional beverages, and dietary supplements, to name a few.
The Expo comes up with lucrative offers, product launches, and show-exclusive prices to the attendees of the Alternative Products Expo. The event is a haven for consumers and investors, as registered buyers and reputed brands showcase their bestsellers and trending innovations at the expo platform. Notable media and marketing partners will provide substantial media coverage and phenomenal social media marketing of the event.
Alternative Products Expo, previously known as USA CBD Expo, has evolved over the years to host one of the finest expos for the counterculture industry. It brings the brightest minds, top industry professionals, and promising newcomers for a memorable lifetime experience.
If you are flying or driving to one of our upcoming AltProExpo events [Atlanta 2024, Miami 2025, Medellin Colombia 2025] you can claim a free $125 flight voucher for 2 people per company, or one $125 voucher if you are driving 3+ hours.
In addition, you may qualify for a free entry pass plus travel coverage. If you own any of the following, we will help cover your flight to bring you to our shows:
Smoke Shop
Gas Station
Distributor Chain
Any business where vape, cannabis, hemp, mushrooms, etc., are sold
CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
After purchasing the retail brand earlier this year, High Tide is launching Queen of Bud branded white label products in its Canna Cabana stores in British Columbia, Alberta, Saskatchewan, Manitoba and Ontario.
High Tide will first launch smoke-eliminating candles in its retail locations, followed by products like a Zippo lighter, as well as pre-rolls and infused blunts in provincial markets where white label cannabis products are allowed.
“Our announcement today follows Alberta’s decision to allow white label sales and underscores how timely our strategic acquisition of the Queen of Bud brand was,” said Raj Grover, founder and CEO of High Tide in a press release. “The thoughtfulness and diligence of our team have brought these highly differentiated and unique products to market for our ELITE and Cabana Club members… New and innovative cannabis product, such as raspberry chocolate diamond infused rose petal blunts and a mango honey live rosin chamomile petal blunt, will launch in the coming weeks, as these products are accepted by provincial wholesalers.”
High Tide plans on the Queen of Bud brand playing a significant part in the company’s approach to white label products, Grover adds with a goal of in-house brands accounting for around one-quarter of all in-store cannabis SKUs within the next five years.
The Queen of Bud Crystal Smoke eliminating candles will be available to High Tide’s ELITE and Cabana Club. The company also recently re-launched its Canna Cabana website for its flagship retail brand, providing an improved experience for its ELITE and Cabana Club members.
High Tide also opened its 183rd Canna Cabana location, which is in Lucan, Ontario. Canna Cabana is the second largest cannabis retailer in the world by store count, and the largest in Alberta.
The cannabis company also recently announced it is partnering with Aberta-based Positive Intent Events (PIE) to bring the Canna Cabana store to event locations across Canada.
“As Canada’s largest retail cannabis chain, we intend to bring the power of our innovative and disruptive discount club model that has helped us achieve almost 11 market share in the Canadian provinces where we operate, into the nascent world of cannabis sales at adults-only events, such as music festivals, comedy shows, and business conferences,” said Raj Grover in a press release earlier this week.
“Partnering with High Tide allows us to seamlessly grow across Canada as regulations make space for cannabis to be included as part of hospitality and tourism,” said Daffyd Roderick, Managing Partner, Positive Intent Events.
“The positive reception we received at the Edmonton International Fringe Theatre Festival confirmed that the public is very ready to embrace cannabis and make it a responsible part of their entertainment experiences,” added Roderick.
Peace Naturals Project Inc. has recalled two lots of cannabis products sold in Ontario due to incorrect cannabinoid values on the products’ labels
The cannabis producer recently recalled one lot of its Spinach Fully Charged Tropical Pack infused pre-rolls cannabis extract and one lot of its Peace Naturals Peppermint 75 CBD cannabis extract.
The total labelled THC for the former is lower than the actual total THC (Lot #017186). The products were labelled as having 0 mg/g THC, while the product should have been labelled as having 400 mg/g THC.
The total THC labelled and total THC per activation for the Peace Naturals Peppermint 75 CBD (Lot #017171) is labelled lower than the actual total THC and the actual total THC per activation, respectively. Total THC is labelled as 1 mg/g, while the actual value is 2 mg/g. The total THC per activation is labelled as 0.3 mg/g. The correct amount is 1 mg THC per activation.
There were 456 units of the recalled Spinach Fully Charged Tropical Pack infused pre-rolls sold in Ontario and 96 units of the recalled Peace Naturals Peppermint 75 CBD. The OCS first listed the recalls on September 6.
Health Canada says that, as of September 10, the Peace Naturals Project Inc. has received two complaints, one for each product, in connection to the labelling. Health Canada has not received any complaints related to the recalled lots. Neither Peace Naturals Project Inc. nor Health Canada have received any adverse reaction reports for the recalled lots of cannabis products.
Health Canada reminds consumers who wish to return an affected product to contact the retail store where the product was purchased.
This is the tenth product recall notice issued by Health Canada so far this year. Labelling errors remain the most common issue for a cannabis product recall in Canada.
A ruling on whether to change cannabis classification to a less dangerous substance in the United States is not expected until after the November election, making it a significant topic in the closely contested presidential race.
Last week, the U.S. Drug Enforcement Administration scheduled a hearing on the proposed changes for Dec. 2, 2024. Given this date, a final decision might not be made until the next presidential administration. Although there’s a chance it could happen before the end of President Biden’s term, marijuana attorney Brian Vicente notes that issuing a decision before Inauguration Day would be a rushed action.
The matter may draw fresh focus to the positions taken by presidential contenders regarding marijuana.
Vice President Kamala Harris has shown support for cannabis decriminalization and expressed disapproval of the drug’s current Schedule 1 listing, where it is classified along with LSD and heroin. Harris’s stance has changed over time, though. She took part in enforcing marijuana laws while serving as California’s attorney general in 2010 and opposed the state’s recreational cannabis legalization.
On the other hand, Donald Trump, the GOP nominee, recently expressed support for a marijuana legalization initiative in Florida, reflecting his growing belief that individuals should not be jailed for cannabis use because it is legal in a majority of states. During his 2016 presidential campaign, Trump supported medical cannabis and suggested that states should decide the legality of cannabis. However, during his term, Jeff Sessions, the then-attorney general, reversed an Obama-era directive that limited federal crackdowns on the cannabis industry in states where it was legal.
Marijuana rescheduling would mark the biggest change to drug policy in the United States in 50 years and might have a significant impact on younger voters. Nonetheless, organizations such as Smart Approaches to Marijuana are against the proposal. Kevin Sabet, president of the organization, contends that insufficient evidence exists to support placing cannabis in the less hazardous schedule 3 category, where it would be placed with drugs such as ketamine.
Sabet stated that the DEA’s decision to hold a hearing was a success in making sure that medical science, not politics, would be the deciding factor. He added that his resistance to the proposal is backed by attorneys general from 18 states.
Rescheduling could enable state-licensed cannabis enterprises to claim federal tax deductions that are presently unavailable to anyone engaged in the trade of schedule I or II substances. Some advocates also hope that rescheduling could push Congress to enact laws that would make it easier for banks to provide services to marijuana businesses. Currently, because of its legal classification, most banks are hesitant to offer financial services to cannabis businesses.
Moreover, rescheduling could also simplify cannabis research, as conducting authorized studies on schedule 1 substances is currently challenging. However, some advocates worry that the debate has become too politicized, with the focus on how rescheduling might impact the industry overshadowing the potential benefits.
All that entities such as Innovative Industrial Properties Inc. (NYSE: IIPR) can do is to wait for the next steps of the rescheduling process to play out so that once the final rule is published, they can determine how the change could impact their business projections.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
A new organization that hopes to help establish standards-based information about cannabis products and companies in Canada is hosting its first workshop in Ottawa in September.
The Cannabis Standards Alliance of Canada (CSAC) is a newly launched not-for-profit organization seeking to establish enforceable industry standards and provide consumers and industry with evidence-based information about cannabis products.
In their first workshop on September 20, the new association will focus on the accuracy of THC values on dried cannabis flower products. The goal of the workshop will be to create standards for sampling practices by producers and analytical labs for testing purposes such as sample selection and preparation.
“CSAC provides the cannabis sector with an alternative to lab shopping/THC inflation, creating a level playing field for producers, labs and dispensaries of all sizes,” said Pierre Killeen, the organization’s Executive Director, in a press release. “Going forward, the Cannabis Standards Alliance of Canada will develop additional enforceable standards helping the sector capitalize on the many opportunities of legal cannabis, both here in Canada and internationally.”
Killian has an extensive history in policy and public affairs and was most recently the executive director of the Institute on Cannabis and the VP of legislative and regulatory affairs at the Cannabis Council of Canada. Before that, he was VP of corporate communications and government relations at Hexo, a Quebec-based cannabis producer.
An investigation by the New Brunswick Department of Justice and Public Safety, in partnership with the Sûreté du Québec, has led to the seizure of over 432 kilograms of dried cannabis believed to be destined for more than 30 unlicensed stores in New Brunswick, Nova Scotia, and Quebec.
Officials say it is believed to be the largest cannabis seizure in Atlantic Canada. Three men from Ontario, a 53-year-old man from Markham, a 45-year-old woman from Scarborough, and a 68-year-old man from Scarborough, were arrested. They face charges under the federal Cannabis Act and Section 354 of the Criminal Code. Section 354 is for “knowing that the property was obtained or derived directly or indirectly by the commission of an offence.”
“Our government has focused on reducing crime and our investments are paying off,” said Public Safety Minister Kris Austin. “This seizure will disrupt the distribution network of dozens of unlicensed cannabis dispensaries, not only in New Brunswick but throughout Canada. This is crucial, as illegal cannabis contributes to and supports organized crime.”
Items seized include:
432.43 kilograms of cannabis bud, valued at over $1.4 million
8,080 pre-rolled cannabis joints
1,658 edible products
925 electronic vape products
241 grams of cannabis derivatives
540 grams of hashish
one kilogram of THC crystals
$143,485 in cash
Images shared by NB Justice and Public Safety show a large amount of dried cannabis, along with package vapes and “copycat” edibles.
New data released by the state of Kentucky shows that almost 5,000 applications were submitted by businesses in the state to acquire licenses to sell medical cannabis. This comes after the state legalized medical marijuana for Kentuckians with different debilitating illnesses in March 2023, when SB 47 was signed into law by Governor Andy Beshear.
The application period for those who wished to participate in the state’s medical marijuana program ran from July 1 to Aug. 31, 2024, with 88% of the applications coming in during the last four days. Applicants were only allowed to file applications for one type of license: processor, dispensary or cultivation.
Officials revealed that 4,096 of the 4,998 applications made were for dispensaries that would sell medical marijuana, while 5 were from safety compliance facilities and 917 applications were for processors and cultivators. The state plans to issue 10 tier-1 cultivation licenses, 4 tier-2 cultivation licenses, 2 tier-3 cultivation licenses, 10 processor licenses, and 48 dispensary licenses.
For dispensaries, the state has been divided into 11 geographic zones, with zones that contain Lexington and Louisville receiving 6 dispensaries each while the remaining zones get 4 dispensaries each. It is expected that each county in a zone will have at least 1 dispensary each, excluding Fayette and Jefferson, which will have 2 dispensaries each. Retail stores will also be allowed to run delivery services.
Gov. Beshear stated that from the results, there was a lot of interest among individuals in the state, adding that this was proof the program would meet its objectives. He provided additional insight into how the permits would be awarded, revealing that a lottery would determine those selected to receive the permits. The Office of Medical Cannabis is already reviewing applications, having increased its staff to ensure the licenses are issued before the year ends.
Despite the significant number of applications, the state plans to issue only 48 permits in 2024. The state decided to limit the number of dispensary licenses to ensure that every patient across the state who needed to access medical cannabis can do so.
Some are concerned that large out-of-state companies may have submitted multiple applications, but the system has been set up to prevent these organizations from gaining an unfair advantage. The state will hold its first lottery next month, with the exact date being announced in the next two weeks. Medical marijuana sales in the state are expected to commence in January 2025.
The positive steps that are being taken to roll out the medical cannabis program in Kentucky are bound to be cheered by the overall industry, including established entities such as Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF), since the patients who need these products will soon access them legally at one of the many licensed facilities within the state.
About CannabisNewsWire
CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
Kombucha is a fermented beverage whose taste reminds of apple cider: it is slightly sweet, acidic, and sparkling. Kombucha consists of two components: a sour liquid broth made of fermented tea in the presence of sucrose, and a flat cellulose pellicle layer.
Kombucha’s popularity is now spread all over the world and is forecast to increase. Half of its consumption is attributed to North America, followed by the European market, with the United Kingdom and Russia leading the consumption. It is also gaining increasing interest in China, where the search for probiotic drinks is very diffused, and in the Middle East and Northern Africa, thanks to this beverage’s health benefits and non-alcoholic nature. [1]
Even though its success is mainly due to Western markets, Kombucha’s origin is set in Eastern Asia, probably in the region of Manchuria, in Northern China, where it was prized by the Tsin Dynasty around 220 B.C thanks to its detoxifying and energizing properties. As a matter of fact, another name for the microbial colony that is responsible for the beverage is “Manchurian mushroom”, along with “tea fungus”.
The etymology of the word “kombucha” is unclear: some theories say it’s the union between the Japanese words kombu (seaweed) and cha (tea), while others support the hypothesis that Kombu was the name of the Korean physician who cured the digestive problems of the Japanese Emperor Inkyo with the tea fungus. With the expansion of trade routes, kombucha arrived in Russia and East Germany, and after World War II it became popular also in France and Italy. [2], [3]
Fermentation Parameters
Kombucha’s fermentation lies on many different factors and not all of them are easy to control, such as the microbiological composition of the broth. However, some of them are particularly crucial for the final taste and properties. One fundamental factor is which substrate is used for fermentation.
The most common is black tea, which represents 75% of total tea production and is obtained by Camellia sinensis’s leaves, after being rolled, oxidized, and dried. Another common substrate is green tea, where leaves are steamed to prevent oxidation of catechins. [1] The absence of the oxidation process gives green tea a lighter flavor and a different polyphenol content.
Even though tea is usually used for Kombucha’s fermentation, other substrates have been tried as an alternative, obtaining similar results. For example, sweetened Echinacea (Echinacea purpurea L.) and winter savory (Satureja montana L.) have given characteristics comparable to traditional Kombucha, but reduced fermentation time; fermented coconut water with Kombucha’s consortium presented different biological activities.
Recently, after only six days of fermentation, Kombucha with improved sensorial and functional properties was obtained by grape juice, which leads to the conclusion that studying therapeutic effects of kombucha obtained by alternative substrates might be a promising direction.
Another key parameter is fermentation time, which usually ranges from 7 to 60 days, when the excess of CO2 creates a starved environment for bacteria to live. After 7 days all kinds of Kombucha’s nutrients are present in the beverage and after the 10th day its taste starts to assume a vinegary taste, due to the increasing concentration of acetic acid.
Furthermore, the pH decreases, due to organic acid concentration: it is important that pH does not get below 3, which is the one of the digestive tract. Finally, fermentation temperature ranges from 22 to 30 °C, but some metabolites, such as vitamin C, were obtained in higher concentrations with temperatures above this threshold. [4]
Biological Composition and Microbial Ecosystem
As previously anticipated, Kombucha’s fermentation is due to a gelatinous consortium of bacteria and yeast that floats on top of the liquid phase and takes the shape of the bowl. [2] Its name is SCOBY, which stands for Symbiotic Culture of Bacteria and Yeasts, and its composition is not unique since it depends on the source of the inoculum for the tea fermentation.
The principal components are both Saccharomyces and non-Saccharomyces osmophilic yeasts, acetic acid, and lactic acid bacteria. [4], [5] The metabolic pathway also remains undefined, since the precise interactions between different microorganisms are unknown. Yeasts are responsible for the first sucrose degradation into glucose and fructose, which can undergo both aerobic and anaerobic fermentation, giving either CO2 or as metabolites. [4]
On the other hand, bacteria produce acetic acid and gluconic acid from ethanol and glucose through aerobic fermentation, respectively. During the first period of fermentation, a biofilm of cellulose is produced thanks to the genus Gluconacetobacter xylinus which synthesizes uridine diphospho-glucose (UDPGlc) – a cellulose’s precursor – from gluconic acid.
Cellulose’s synthesis increases as long as the presence of oxygen at the medium/air interface is guaranteed, allowing only the bacteria on the surface to maintain their activity, whereas the ones that are in the liquid are kept in a dormant state due to the progressive lack of oxygen and can be used for further inocula. [4] [6] However, when SCOBY becomes too thick and starts to sink into the liquid, the oxygen supply is insufficient for bacteria to carry out their metabolic activity and cellulose’s production stops.
On the other hand, while bacteria perform aerobic fermentation on the surface, yeasts are kept on SCOBY’s bottom, where oxygen supply is reduced and anaerobic fermentation leads to the production of ethanol and other fruity organic compounds, that are responsible for kombucha’s aromas. [5]
The presence of both Saccharomyces and non-Saccharomyces yeasts avoids the risk of stuck fermentation and the production of organic acids, and the consequent pH decrease, inhibits pathogenic bacteria’s growth, enabling safe drinking. [4]
Chemical Composition and Properties
Many bioactive compounds in Kombucha are the ones contained in green and black tea. These plants are renowned for their high polyphenol content, the most abundant antioxidants in the diet. The main polyphenols in green tea are catechins, that in black tea are oxidized to thea-flavins and thea-rubigins, causing a less bitter taste and a darker color.
Polyphenols are associated with:
the prevention of cancer
increased immunity
Arthritis prevention
and inflammation reduction.
Another class of abundant compounds due to bacteria fermentation are organic acids and their content strongly depends on the starter culture used. Acetic acid is responsible for kombucha’s vinegary flavor, and its concentration reaches its peak of 11 g/L on day 30 of fermentation and then starts to drop since, after the depletion of sugar and ethanol, bacteria start to use acetic acid as a carbon source. Lactic acid is mainly found in Kombucha made from green tea.
The metabolism of glucose produces glucuronic acid which is the most significant detoxifier in the human organism. [1], [6] Naturally produced by a healthy liver, its function is to conjugate different lipidic compounds through a process called glucuronidation, producing more hydrophilic molecules that can be excreted through the kidneys or the digestive tract.
Glucuronic acid is also important as a precursor in the biosynthesis of L-ascorbic acid (AA), also known as vitamin C, in acetic acid bacteria. AA is a water-soluble vitamin that, like all the other vitamins, is not synthesized within the body and has to be supplemented in the diet. Vitamin C is found in many vegetables and fruits such as citrus fruits, peppers, broccoli, and strawberries.
It has numerous functions, first of all protecting the immune system, reducing cholesterol levels, and collagen synthesis. Collagen is the principal fibrous protein of animals’ connective tissue, hence AA plays a crucial role in wound repair and healing/regeneration process. [1], [7]
Amino acids belong to another class of compounds that is commonly found in food and beverages. Many of them have been identified in tea, the most abundant being theanine, accounting for 50% of total amino acids. Even though this class of compounds is essential for the human organism, one of their byproducts, biogenic amines (BAs), represents a threat to health when contained in high ratios.
BAs, such as histamine, putrescine, or serotonin are produced endogenously through of amino acids and are essential for several metabolic activities. However, BAs can also be produced by decarboxylase-positive microorganisms in fermented food and beverages. In this case, BAs content might exceed the toxic threshold and some toxic effects might occur.
Hence, in non-fermented beverages, no BA content is a quality indicator, stating the absence of unwanted microorganisms. However, even though three potential BAs precursors have been identified in Kombucha (lysine, phenylalanine, and tryptophan), no BAs have been found in the analyzed samples.
Ethanol is present in Kombucha in a range of 0.7-1.3% by volume, as a byproduct of yeast fermentation, while caffeine serves as an essential nitrogen source for yeasts and bacteria to build new cells. [1]
Alongside all the beneficial properties attributed to the above mentioned compounds, the presence of the whole plethora of Kombucha’s microorganisms provides this beverage with probiotic effects, i.e. live microorganisms that, when consumed, cause beneficial changes in a person’s gut microbiota. [1]
However, there is a lack of scientific data about Kombucha’s beneficial properties and a few cases of adverse effects have been reported. However, in all cases, side conditions, such as existing pathologies, might have contributed to the acuity of the intoxication. A very important factor to keep under control to avoid unwanted contamination is to work under hygienic conditions [6].
Furthermore, pregnant women should avoid drinking Kombucha because of the presence of heparin, a protein contained in the tea that inhibits the blood-clotting system. Tea also contains tannins, polyphenols that cause tooth stains by binding to the hydroxyapatite component of the enamel. However, this kind of stain can be removed by bleaching treatment. [1], [3], [6]
Cellulose Biofilm
As anticipated above, the species Gluconobacter xylinum is not capable of synthesizing acetic acid from ethanol, but instead one of its metabolic pathways leads to the formation of a cellulosic biofilm.
This microbial cellulose is secreted through 3.5 nm-diameter pores and lies extracellularly in the form of fibrils attached to the bacterial cell. Each newly produced film is called “daughter” and is the closest to the surface, while the SCOBY is also known as the “mother” and consists of all the previous overlapped film layers that are located below the most recent one. [5]
This kind of cellulose exists into two forms, cellulose I and II. The first is a ribbon-like polymer that forms crystals, while the second is an amorphous polymer, more thermodynamically stable. It is hypothesized that Kombucha’s colonies might produce a different cellulose polymer than the one obtained by standard sources.
The main difference between Kombucha derived cellulose and plant-derived one, is the first one’s purity. Indeed, polymers such as hemicellulose, lignin, or pectin are completely absent. Furthermore, this biofilm is 100 times thinner than the one obtained from plants, but its water-holding capacity is over 100 times higher. [4]
A similar cellulosic floating network obtained by the fermentation of coconut water is a popular delicacy in the Philippines called “Nata de Coco” and other microbial cellulosic biofilms have been known to be used in Brazil to heal skin burns and other dermal injuries since ancient times. [3]
However, its astonishing properties make the SCOBY a promising candidate for innovative materials, even though the production costs remain a limitation for such applications. This material has been studied as an alternative eco-packaging, a biomaterial for medicine, and a supplement for animal feeding. [8] However, it showed its most promising results in the bio-absorption of heavy metals in aqueous solutions such as wastewater. [3], [5]
These results make Kombucha an interesting topic to be further explored not only for its potential health benefits, about whom data are still insufficient, but also as a promising new generation material.
References:
[1] P. Bishop, E. R. Pitts, D. Budner, and K. A. Thompson-Witrick, “Chemical Composition of Kombucha,” Sep. 01, 2022, MDPI. doi: 10.3390/beverages8030045.
[2] J. Jarrell, T. Cal, and J. W. Bennett, “The Kombucha consortia of yeasts and bacteria,” Mycologist, vol. 14, no. 4, pp. 166–170, 2000, doi: 10.1016/S0269-915X(00)80034-8.
[3] R. Jayabalan, R. V. Malbaša, E. S. Lončar, J. S. Vitas, and M. Sathishkumar, “A review on kombucha tea-microbiology, composition, fermentation, beneficial effects, toxicity, and tea fungus,” 2014, Blackwell Publishing Inc. doi: 10.1111/1541-4337.12073.
[4] S. A. Villarreal-Soto, S. Beaufort, J. Bouajila, J. P. Souchard, and P. Taillandier, “Understanding Kombucha Tea Fermentation: A Review,” Mar. 01, 2018, Blackwell Publishing Inc. doi: 10.1111/1750-3841.14068.
[5] R. M. D. Coelho, A. L. de Almeida, R. Q. G. do Amaral, R. N. da Mota, and P. H. M. de Sousa, “Kombucha: Review,” Dec. 01, 2020, AZTI-Tecnalia. doi: 10.1016/j.ijgfs.2020.100272.
[6] J. M. Leal, L. V. Suárez, R. Jayabalan, J. H. Oros, and A. Escalante-Aburto, “A review on health benefits of kombucha nutritional compounds and metabolites,” CYTA – Journal of Food, vol. 16, no. 1, pp. 390–399, Jan. 2018, doi: 10.1080/19476337.2017.1410499.
[7] S. Chambial, S. Dwivedi, K. K. Shukla, P. J. John, and P. Sharma, “Vitamin C in disease prevention and cure: An overview,” Oct. 01, 2013, Springer. doi: 10.1007/s12291-013-0375-3.
[8] I. Diez-Ozaeta and O. J. Astiazaran, “Recent advances in Kombucha tea: Microbial consortium, chemical parameters, health implications and biocellulose production,” Sep. 16, 2022, Elsevier B.V. doi: 10.1016/j.ijfoodmicro.2022.109783.
Recent Comments